Medical Equipment

Surge In Liver Cancer Cases Fueling The Growth Of The Market Due To Rising Prevalence And Mortality Rates Is Contributing To Changes In The Liver Cancer Diagnostics Market

April 14, 2026April 14, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Liver Cancer Diagnostics Market In 2026 And 2030?

The liver cancer diagnostics market size has exhibited robust growth in recent years. It is anticipated to expand from $10.32 billion in 2025 to $11.07 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.3%. This historical growth can be attributed to an increasing prevalence of chronic liver diseases, a rising incidence of hepatocellular carcinoma, the expansion of hospital diagnostic infrastructure, growing awareness for early cancer screening, and advancements in imaging and pathology techniques.

The liver cancer diagnostics market size is projected to experience significant growth in the upcoming years. This market is expected to reach $14.75 billion by 2030, with a compound annual growth rate (CAGR) of 7.4%. This anticipated expansion during the forecast period is primarily driven by the increasing adoption of precision oncology diagnostics, a rising demand for non-invasive diagnostic methods, the broadening of molecular testing capabilities, growing investments in oncology research, and the expanding use of AI-assisted diagnostic platforms. Key developments projected for this period encompass the rising uptake of advanced molecular diagnostic tests, greater utilization of imaging-based early detection tools, the increasing integration of biomarker-based screening methods, an enlargement of personalized oncology diagnostics, and a sharpened emphasis on identifying cancer at early stages.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

What Significant Factors Are Influencing The Liver Cancer Diagnostics Market Expansion?

An increasing incidence of liver cancer is anticipated to stimulate expansion in the liver cancer diagnostics market moving ahead. This condition, liver cancer, involves the uncontrolled proliferation of liver cells, leading to a severe and life-threatening disease. Diagnostic tests for liver cancer are conducted to ascertain if malignant cells are disseminating within or around the liver following an initial diagnosis of primary liver carcinoma, thus, the increasing occurrence of liver cancer fuels the liver cancer diagnostics market. For example, data from the Cancer Facts & Figures 2023 report, released in January 2023 by the American Cancer Society, a US-based voluntary health organization, indicated that new cases of liver and intrahepatic bile duct cancer among US females totaled 13,230 in 2023. Additionally, in 2023, approximately 41,210 new diagnoses of liver cancer were made in the US, with an anticipated 29,380 fatalities. Consequently, the growing incidence of liver cancer is a key factor propelling the expansion of the liver cancer diagnostics market.

What Are The Key Segment Divisions In The Liver Cancer Diagnostics Market Segment Structure?

The liver cancer diagnostics market covered in this report is segmented –

1) By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma

2) By Screening: Laboratory Testing, Imaging, Biopsy, Other Screenings

3) By Technology: Fluorescent In Situ Hybridization (FISH), Immunohistochemical (IHC), Other Technologies

4) By End Use: Hospitals And Diagnostic Laboratories, Academic And Research Institutes

Subsegments:

1) By Hepatocellular Carcinoma: Early-Stage Hepatocellular Carcinoma, Advanced-Stage Hepatocellular Carcinoma

2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma

3) By Hepatoblastoma: Pure Hepatoblastoma, Mixed Hepatoblastoma

What Trends Are Affecting The Direction Of The Liver Cancer Diagnostics Market?

Prominent companies in the **liver cancer diagnostics market** are developing sophisticated biomarker-based assays and algorithms to enhance diagnostic accuracy and aid in early detection. Biomarker-based assays and algorithms are diagnostic tools that utilize specific biological markers to identify diseases, offering more precise and efficient diagnostic capabilities. For example, in **November 2023**, **Roche Diagnostics**, a **US**-based biotech corporation, introduced the **Elecsys PIVKA-II assay** and **Elecsys GAAD algorithm**. The **Elecsys PIVKA-II assay** identifies elevated levels of the **PIVKA-II** biomarker, which is linked to hepatocellular carcinoma (**HCC**), thereby improving early detection of liver cancer in high-risk patients. The **Elecsys GAAD algorithm** combines multiple diagnostic markers, such as **PIVKA-II** and **AFP**, to increase diagnostic precision and streamline decision-making in liver cancer detection.

Which Organizations Are Engaged In The Liver Cancer Diagnostics Market?

Major companies operating in the liver cancer diagnostics market are Abbott Laboratories, F Hoffmann La Roche Ltd, Qiagen NV, Thermo Fisher Scientific Inc, Siemens Healthineers, Illumina Inc, Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc, Danaher Corporation, Foundation Medicine Inc, Agilent Technologies Inc, Genemed Biotechnologies Inc, Merck KGaA, Fujifilm Medical Systems USA Inc, GE Healthcare, Advanced Cell Diagnostics Inc, Oxford Gene Technology, Leica Biosystems Nussloch GmbH, Exiqon AS, BioGenex Laboratories Inc, OncoCyte Corporation, Guardant Health Inc, Exact Sciences Corporation, Grail Inc, Freenome Holdings Inc, Natera Inc, Personal Genome Diagnostics Inc, Thrive Earlier Detection Corp

Get The Full Liver Cancer Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Which Region Is The Top Contributor To The Liver Cancer Diagnostics Market By Share?

North America was the largest region in the liver cancer diagnostics market in 2025. The regions covered in the liver cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Liver Cancer Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Liver Cancer Diagnostics Market 2026, By The Business Research Company

Liver Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-health-supplements-global-market-report

Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Unresectable Hepatocellular Carcinoma Market Report 2026

https://www.thebusinessresearchcompany.com/report/unresectable-hepatocellular-carcinoma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795